Tenderwize
Retour à la recherche

Open House Discount Agreement for Zolmitriptan

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 163 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zolmitriptan, ATC N02CC03

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

The authority reserves the right to replace Open House agreements with exclusive discount agreements during the contrac...

No estimated value or volume is provided, so the potential business volume is unknown.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing Zolmitriptan (ATC N02CC03)
  • Non-exclusive discount agreements with uniform conditions
Afficher le résumé complet

This is an Open House (non-exclusive) discount agreement procedure by AOK Rheinland-Pfalz/Saarland for pharmaceutical products containing the active substance Zolmitriptan (ATC N02CC03). The contracting authority offers uniform, non-negotiable contracts to any interested pharmaceutical company without selection. Contracts run for a maximum of 24 months starting from June 1, 2025, with the possibility of joining on the first of any month. The procedure is explicitly stated not to be a public procurement under EU directive 2014/24/EU but is published for transparency. No estimated value is provided. Submission is paper-based only. The initial deadline for the first wave of contracts is April 30, 2025; later joiners must submit by the end of the month prior to the desired start.

Risques

The authority reserves the right to replace Open House agreements with exclusive discount agreements during the contrac...

No estimated value or volume is provided, so the potential business volume is unknown.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Products must be authorized and marketable in Germany
  • Evidence of marketability via Lauer-Taxe listing or AMIce database extract

Administrative

  • Paper-based submission (electronic submission not allowed)

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria specified; contracts are offered on a take-it-or-leave-it basis to all participants.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Agreement for Zolmitriptan

Non-exclusive discount agreements for Zolmitriptan (ATC N02CC03) under an Open House model. All interested pharmaceutical companies can join under uniform terms. Contracts may be terminated early if the authority awards exclusive discount agreements via a separate tendering process. The maximum contract duration is 24 months. Children's medicines according to BfArM list are excluded.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria specified; contracts are offered on a take-it-or-leave-it basis to all participants.

Date limite

Deadline Mar 31, 2027

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
237213-2025

Documents (1)

Appels d'offres similaires